These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2967329

  • 21. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity.
    Vanhaesebroeck B, Reed JC, De Valck D, Grooten J, Miyashita T, Tanaka S, Beyaert R, Van Roy F, Fiers W.
    Oncogene; 1993 Apr; 8(4):1075-81. PubMed ID: 8455935
    [Abstract] [Full Text] [Related]

  • 22. Adenosine and homocysteine together enhance TNF-mediated cytotoxicity but do not alter activation of nuclear factor-kappa B in L929 cells.
    Bergmann S, Shatrov V, Ratter F, Schiemann S, Schulze-Osthoff K, Lehmann V.
    J Immunol; 1994 Aug 15; 153(4):1736-43. PubMed ID: 8046241
    [Abstract] [Full Text] [Related]

  • 23. Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation.
    Wallis RA, Panizzon KL, Henry D, Wasterlain CG.
    Neuroreport; 1993 Dec 13; 5(3):245-8. PubMed ID: 8298082
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.
    Laster SM, Wood JG, Gooding LR.
    J Immunol; 1988 Oct 15; 141(8):2629-34. PubMed ID: 3171180
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. ADP-ribosylation inhibitors inhibit cellular RNA synthesis but do not affect expression of manganous superoxide dismutase or heat shock protein 70 in tumor necrosis factor alpha-sensitive and -resistant tumor cells.
    Tang P, Hung MC, Klostergaard J.
    J Interferon Cytokine Res; 1995 Sep 15; 15(9):791-7. PubMed ID: 8536107
    [Abstract] [Full Text] [Related]

  • 29. The role of iron in the cytotoxicity of tumor necrosis factor.
    Warren S, Torti SV, Torti FM.
    Lymphokine Cytokine Res; 1993 Apr 15; 12(2):75-80. PubMed ID: 8324080
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
    Bektaş M, Nurten R, Ergen K, Bermek E.
    Cell Biochem Funct; 2006 Apr 15; 24(4):369-80. PubMed ID: 16142694
    [Abstract] [Full Text] [Related]

  • 32. ADP-ribosylation, DNA repair, cell differentiation and cancer.
    Shall S.
    Princess Takamatsu Symp; 1983 Apr 15; 13():3-25. PubMed ID: 6317641
    [Abstract] [Full Text] [Related]

  • 33. Protective effect of nicotinamide and 3-aminobenzamide on islet cell damage induced by gamma-interferon and tumor necrosis factor.
    Yamada K, Ryu E, Nonaka K.
    Diabetes Res; 1990 Feb 15; 13(2):85-7. PubMed ID: 2151129
    [Abstract] [Full Text] [Related]

  • 34. Synergistic enhancement of 6-thioguanine cytotoxicity by ADP-ribosyltransferase inhibitors.
    Moses K, Harris AL, Durkacz BW.
    Cancer Res; 1988 Oct 15; 48(20):5650-4. PubMed ID: 3139280
    [Abstract] [Full Text] [Related]

  • 35. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
    Nissen-Meyer J, Hofsli E, Espevik T, Austgulen R.
    Nat Immun Cell Growth Regul; 1988 Oct 15; 7(5-6):266-79. PubMed ID: 3146697
    [Abstract] [Full Text] [Related]

  • 36. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
    Ziegler-Heitbrock HW, Möller A, Linke RP, Haas JG, Rieber EP, Riethmüller G.
    Cancer Res; 1986 Nov 15; 46(11):5947-52. PubMed ID: 3756932
    [Abstract] [Full Text] [Related]

  • 37. Bacteria-infected fibroblasts have enhanced susceptibility to the cytotoxic action of tumor necrosis factor.
    Klimpel GR, Shaban R, Niesel DW.
    J Immunol; 1990 Jul 15; 145(2):711-7. PubMed ID: 1694886
    [Abstract] [Full Text] [Related]

  • 38. Effects of inhibitors of ADP-ribosylation on macrophage activation.
    Le Page C, Pellat-Deceunynck C, Drapier JC, Wietzerbin J.
    Adv Exp Med Biol; 1997 Jul 15; 419():203-7. PubMed ID: 9193655
    [Abstract] [Full Text] [Related]

  • 39. Induction of nitric oxide synthase in L929 cells by tumour-necrosis factor alpha is prevented by inhibitors of poly(ADP-ribose) polymerase.
    Hauschildt S, Scheipers P, Bessler WG, Mülsch A.
    Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):255-60. PubMed ID: 1280112
    [Abstract] [Full Text] [Related]

  • 40. Influence of ADP-ribosyltransferase inhibitors on the intracellular NAD and ATP levels in Ehrlich ascites tumor cells: implication for the altered NAD + ATP-dependent cellular sensitivity to the cytotoxic agents.
    Hoshino J, Schalge S, Drevenstedt B, Kröger H.
    Biochem Int; 1990 Nov 15; 20(1):135-45. PubMed ID: 1691642
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.